Vertex Pharma after-hours: EUR 448.95, prior close EUR 451.65

Published on 10/08/2026 at 22:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At 10:50 p.m. CEST on October 8, Vertex Pharma was at EUR 448.95 in after-hours trading at Lang & Schwarz, down 0.60 percent versus the prior close.

Key points in brief

Vertex Pharma traded at EUR 448.95 after-hours at Lang & Schwarz.
The stock was down 0.60 percent versus the prior close.
The S&P 500 ended October 8 down 0.46 percent at 7,765.70.

Flatlay-Anordnung mit Zertifikat, ISIN-Karte, Pipette, Fläschchen und Stethoskop — Vertex Pharma US92532F1003 präsentiert eine Flatlay-Anordnung mit Aktienzertifikat, ISIN-Karte und typischen Laborutensilien, Illustration mit AI erstellt.

Vertex Pharma was at EUR 448.95 in after-hours trading at 10:50 p.m. CEST on October 8, 2026, according to Lang & Schwarz. The price was down 0.60 percent versus the prior close of EUR 451.65. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CEST is shown by the continuously updated real-time quote of Vertex Pharma stock.

Daily balance: Lang & Schwarz showed a bid of EUR 448.05 and an ask of EUR 449.85. The S&P 500 fell 36.07 points, or 0.46 percent, to 7,765.70 on October 8, according to Reuters.

Upcoming company date

Vertex Pharmaceuticals Incorporated said on October 7 that it will report third-quarter 2026 financial results on November 2 after the financial markets close and host a conference call at 4:30 p.m. ET, according to the company's Investor Relations release.